Avio Smart Market Stack Ltd has revised its investment disclosure for Huwel Lifesciences Private Limited to ₹7.5 crore. This update clarifies the total consideration and stake acquired, emphasizing regulatory filing accuracy.
Avio Smart Market Stack Revises Huwel Lifesciences Investment
Avio Smart Market Stack Ltd has updated its investment details in Huwel Lifesciences Private Limited, revising the total investment to ₹7.5 crore (₹750 lakh) from a previous disclosure of ₹4 crore (₹400 lakh).
Reader Takeaway: Increased investment in healthcare diagnostics, but revision flags disclosure accuracy.
What just happened
The company announced a revised investment amount for its stake in Huwel Lifesciences Private Limited. The total consideration has been increased to ₹7.5 crore. This follows an earlier intimation on April 08, 2026, which reported an investment of ₹4 crore.
Why this matters
This clarification provides a clearer picture of Avio Smart Market Stack's financial commitment to Huwel Lifesciences. The revised figure of ₹7.5 crore reflects a significant increase in the investment scale. The acquisition aims to create operational and financial synergies within the healthcare and diagnostics sector.
The backstory
Huwel Lifesciences Private Limited, the target company, is involved in the development, manufacturing, and supply of molecular diagnostic kits, medical devices, and in-vitro diagnostic solutions. It serves hospitals, laboratories, and research institutions. The company's turnover has seen fluctuations, with ₹12.11 crore in FY 2022-23, ₹4.94 crore in FY 2023-24, and ₹15.74 crore in FY 2024-25.
What changes now
The revised disclosure confirms that Avio Smart Market Stack has acquired 9,665 equity shares in Huwel Lifesciences at a price of ₹7,760 per share. This represents a 2.06% equity stake. The transaction is confirmed to be at arm's length, with no interest from the promoter group in the target entity.
Risks to watch
A key watch point is the revision of the initial disclosure. While the acquisition is finalized, the need to correct previous regulatory filings highlights the importance of robust internal reporting controls and accurate disclosures to investors.
Context metrics (time-bound)
Avio Smart Market Stack Ltd's revised investment in Huwel Lifesciences Private Limited is ₹7.5 crore (as of April 08, 2026 filing update), acquiring a 2.06% stake at ₹7,760 per share. Previously reported as ₹4 crore.
Huwel Lifesciences turnover: FY 2022-23: ₹12.11 crore, FY 2023-24: ₹4.94 crore, FY 2024-25: ₹15.74 crore.